MGP

> Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis

> Statin therapy is associated with lower prevalence of gut microbiota dysbiosis

> Gut bacteria composition drives primary resistance to cancer immunotherapy in renal cell carcinoma Patients

> Impact of bariatric surgery (LSG vs LRYGB) on the gut microbiome

> Beneficial effects of a Mediterranean diet in overweight and obese subjects

> Low FODMAP diet and gut mcirobiome

> Handling and Storage of Stool Samples Intended for Fecal Microbiome Transplantation

> Abundance-based reconstitution of microbial pan-genomes

> Novel role of butyrate as AhR ligand in human intestinal epithelial cells

> Butyrate and human intestinal epithelial cells

> Prediction of the intestinal resistome

> Effect on SCFAs in human enteroendocrine cells

> Microbiome and melanoma cancer immunotherapy

> Microbiome and epithelial cancer immunotherapy

> Standards for microbiome studies

> Commensal gut bacteria modulate phosphorylation-dependent PPARγ transcriptional activity in human intestinal epithelial cells

> A fibrolytic potential in the human ileum mucosal microbiota

> A pig gut gene catalog

> Microbiome and insuline resistance

> Drug confounders in microbiome analysis

> A mouse gut gene catalogue

> Functional metagenomics to decipher food–microbe–host crosstalk

> Human gut microbiome alterations in liver cirrhosis

> 10 millions genes reference catalog

> Method for identifying metagenomic species

> Universal phylogenetic markers

> Richness of gut microbes and metabolic markers

> Impact of diet on gut microbiome

> Type II Diabetes

> Impact of room temperature versus freezing

> Enterotypes

> The human gut reference catalogue